Freezing of gait treatment market to exhibit productive growth during the forecast period
The global freezing of gait treatment market is growing effectually, expected to grow at a CAGR of 7.2%. Globally, increasing prevalence of Parkinson's disease has significantly increased the revenue of oral dopaminergic medications. FDA approval for new drugs, and promising pipeline products in the equipment and devices segment in the Parkinson's disease industry are driving the overall growth freezing of gait treatment market globally.Oral dopaminergic medication segment is expected to register higher growth by the end of 2030
Levodopa (Inbrija™, by Acorda Therapeutics), along with carbidopa, remains the optimum standard of symptomatic treatment for (FoG) Parkinson disease orally. In Dec 2020, the U.S. FDA approved Inbrija™ for the alternating treatment of OFF incidents in people with Parkinson’s disease who are already treated with levodopa/carbidopa. It is a novel approach for the treatment of OFF periods in PD. Advanced pipeline products in the wearable and walking aid segment will show promising growth in near future. For e.g. In the CES 2020 conference in Las Vegas, a Chinese company named GYENNO showcased its gait aid equipment package, mainly helps to escape gait freeze in Parkinson’s patients. Additionally, Kyungpook National University showcased android based gait-aid system by using smart glasses with wearable sensors.Increasing admissions for freezing of gait in the hospital segment to witness a significant CAGR
Increasing chronic Parkinson’s disease (PD) along with significant admissions in the hospitals internationally are notable factors expected for the growth of the market. According to FDA and other research studies, symptomatic and neuroprotective therapies are opted for PD in hospitals. Deep brain stimulation procedures along with helpful brain exercises are also adopted in the end user segment, showed promising results in recent time. Moreover, increasing elderly population along with increasing admissions is escalating the growth in the end-user segment. Moreover, lunch of new medications and equipment in the U.S. market and internationally along with increased funding for PD patient care for the administrations of freezing of gait treatment on a global scale will drive the growth during the forecast period.Increasing population, new FDA approval and the presence of top players holds the U.S. in dominant position
In 2021, the U.S contributed maximum revenue share in the freezing of gait treatment market due to the rising prevalence of PD. Key prime factors include rising awareness about new medications and therapies, FDA approvals for new drugs, and rising PD care services along with enhanced reimbursement structure will drive the demand in near future. Emerging nations always suffer the burden of chronic diseases. Nevertheless, there is no significant treatment targeted towards freezing of gait in PD, but strong pipeline drugs and products along with the approval for levodopa will further enhance the growth on a global scale.Increased research and development with strong product pipelines in the developed regions
Major players in the freezing of gait treatment market are Acorda Therapeutics, The Michael J. Fox Foundation, GYENNO, National University of Ireland, Galway (NUI Galway), Kyungpook National University, Republic of Korea, MedEXO Robotics, TABLE Teva Pharmaceuticals and others. Major organizations and research centers are developing progressive technologies with new technology expansion in the wearable and walking aids systems, electronic brain implants and other stimulators for freezing of gait treatment on a global scale.The current report also comprehends qualitative and qualitative market valuation factors such as key market drivers, market trends, restraints and opportunities that gives a better market understanding of the overall freezing of gait treatment market. Additionally, the global report also comprises graphical representation of competitive landscape based on their market initiatives and strategies, product portfolio and business strengths.
Historical & Forecast Period
This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Freezing of Gait Treatment market are as follows:- Research and development budgets of manufacturers and government spending
- Revenues of key companies in the market segment
- Number of end users and consumption volume, price and value.
- Geographical revenues generate by countries considered in the report
- Micro and macro environment factors that are currently influencing the Freezing of Gait Treatment market and their expected impact during the forecast period.
Market Segmentation
Treatment
- Oral Dopaminergic Medication (Inbrija - levodopa inhalation powder)
- Wearable and Walking Aid Devices
- Deep Brain Stimulation
- Others (Brain Implants)
End User
- Hospitals
- Clinics
- Research and Academic Institutes
Key questions answered in this report
- What are the key micro and macro environmental factors that are impacting the growth of Freezing of Gait Treatment market?
- What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
- Estimated forecast and market projections up to 2030.
- Which segment accounts for the fastest CAGR during the forecast period?
- Which market segment holds a larger market share and why?
- Are low and middle-income economies investing in the Freezing of Gait Treatment market?
- Which is the largest regional market for Freezing of Gait Treatment market?
- What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
- Which are the key trends driving Freezing of Gait Treatment market growth?
- Who are the key competitors and what are their key strategies to enhance their market presence in the Freezing of Gait Treatment market worldwide?
This product will be delivered within 2 business days.
Table of Contents
1. Preface1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Freezing of Gait Treatment Market
2.2. Global Freezing of Gait Treatment Market, By Treatment, 2021 (US$ Million)
2.3. Global Freezing of Gait Treatment Market, By End User, 2021 (US$ Million)
2.4. Global Freezing of Gait Treatment Market, By Geography, 2021 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2021
3. Freezing of Gait Treatment Market: Competitive Analysis
3.1. Market Positioning of Key Freezing of Gait Treatment Market Vendors
3.2. Strategies Adopted by Freezing of Gait Treatment Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2021 Versus 2030
4. Freezing of Gait Treatment Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Freezing of Gait Treatment Market Value, 2020 - 2030, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
5. Freezing of Gait Treatment Market: By Treatment, 2020-2030, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2021 Versus 2030
5.3. Market Segmentation
5.3.1. Oral Dopaminergic Medication (Inbrija - levodopa inhalation powder)
5.3.2. Wearable and Walking Aid Devices
5.3.3. Deep Brain Stimulation
5.3.4. Others (Brain Implants)
6. Freezing of Gait Treatment Market: By End User, 2020-2030, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2021 Versus 2030
6.3. Market Segmentation
6.3.1. Hospitals
6.3.2. Clinics
6.3.3. Research and Academic Institutes
7. North America Freezing of Gait Treatment Market, 2020-2030, USD (Million)
7.1. Market Overview
7.2. Freezing of Gait Treatment Market: By Treatment, 2020-2030, USD (Million)
7.3. Freezing of Gait Treatment Market: By End User, 2020-2030, USD (Million)
7.4.Freezing of Gait Treatment Market: By Region, 2020-2030, USD (Million)
7.4.1.North America
7.4.1.1. U.S.
7.4.1.1.1. Freezing of Gait Treatment Market: By Treatment, 2020-2030, USD (Million)
7.4.1.1.1. Freezing of Gait Treatment Market: By End User, 2020-2030, USD (Million)
7.4.1.2. Canada
7.4.1.2.1. Freezing of Gait Treatment Market: By Treatment, 2020-2030, USD (Million)
7.4.1.2.1. Freezing of Gait Treatment Market: By End User, 2020-2030, USD (Million)
7.4.1.3. Rest of North America
7.4.1.3.1. Freezing of Gait Treatment Market: By Treatment, 2020-2030, USD (Million)
7.4.1.3.1. Freezing of Gait Treatment Market: By End User, 2020-2030, USD (Million)
8. UK and European Union Freezing of Gait Treatment Market, 2020-2030, USD (Million)
8.1. Market Overview
8.2. Freezing of Gait Treatment Market: By Treatment, 2020-2030, USD (Million)
8.3. Freezing of Gait Treatment Market: By End User, 2020-2030, USD (Million)
8.4.Freezing of Gait Treatment Market: By Region, 2020-2030, USD (Million)
8.4.1.UK and European Union
8.4.1.1. UK
8.4.1.1.1. Freezing of Gait Treatment Market: By Treatment, 2020-2030, USD (Million)
8.4.1.1.1. Freezing of Gait Treatment Market: By End User, 2020-2030, USD (Million)
8.4.1.2. Germany
8.4.1.2.1. Freezing of Gait Treatment Market: By Treatment, 2020-2030, USD (Million)
8.4.1.2.1. Freezing of Gait Treatment Market: By End User, 2020-2030, USD (Million)
8.4.1.3. Spain
8.4.1.3.1. Freezing of Gait Treatment Market: By Treatment, 2020-2030, USD (Million)
8.4.1.3.1. Freezing of Gait Treatment Market: By End User, 2020-2030, USD (Million)
8.4.1.4. Italy
8.4.1.4.1. Freezing of Gait Treatment Market: By Treatment, 2020-2030, USD (Million)
8.4.1.4.1. Freezing of Gait Treatment Market: By End User, 2020-2030, USD (Million)
8.4.1.5. France
8.4.1.5.1. Freezing of Gait Treatment Market: By Treatment, 2020-2030, USD (Million)
8.4.1.5.1. Freezing of Gait Treatment Market: By End User, 2020-2030, USD (Million)
8.4.1.6. Rest of Europe
8.4.1.6.1. Freezing of Gait Treatment Market: By Treatment, 2020-2030, USD (Million)
8.4.1.6.1. Freezing of Gait Treatment Market: By End User, 2020-2030, USD (Million)
9. Asia Pacific Freezing of Gait Treatment Market, 2020-2030, USD (Million)
9.1. Market Overview
9.2. Freezing of Gait Treatment Market: By Treatment, 2020-2030, USD (Million)
9.3. Freezing of Gait Treatment Market: By End User, 2020-2030, USD (Million)
9.4.Freezing of Gait Treatment Market: By Region, 2020-2030, USD (Million)
9.4.1.Asia Pacific
9.4.1.1. China
9.4.1.1.1. Freezing of Gait Treatment Market: By Treatment, 2020-2030, USD (Million)
9.4.1.1.1. Freezing of Gait Treatment Market: By End User, 2020-2030, USD (Million)
9.4.1.2. Japan
9.4.1.2.1. Freezing of Gait Treatment Market: By Treatment, 2020-2030, USD (Million)
9.4.1.2.1. Freezing of Gait Treatment Market: By End User, 2020-2030, USD (Million)
9.4.1.3. India
9.4.1.3.1. Freezing of Gait Treatment Market: By Treatment, 2020-2030, USD (Million)
9.4.1.3.1. Freezing of Gait Treatment Market: By End User, 2020-2030, USD (Million)
9.4.1.4. Australia
9.4.1.4.1. Freezing of Gait Treatment Market: By Treatment, 2020-2030, USD (Million)
9.4.1.4.1. Freezing of Gait Treatment Market: By End User, 2020-2030, USD (Million)
9.4.1.5. South Korea
9.4.1.5.1. Freezing of Gait Treatment Market: By Treatment, 2020-2030, USD (Million)
9.4.1.5.1. Freezing of Gait Treatment Market: By End User, 2020-2030, USD (Million)
9.4.1.6. Rest of Asia Pacific
9.4.1.6.1. Freezing of Gait Treatment Market: By Treatment, 2020-2030, USD (Million)
9.4.1.6.1. Freezing of Gait Treatment Market: By End User, 2020-2030, USD (Million)
10. Latin America Freezing of Gait Treatment Market, 2020-2030, USD (Million)
10.1. Market Overview
10.2. Freezing of Gait Treatment Market: By Treatment, 2020-2030, USD (Million)
10.3. Freezing of Gait Treatment Market: By End User, 2020-2030, USD (Million)
10.4.Freezing of Gait Treatment Market: By Region, 2020-2030, USD (Million)
10.4.1.Latin America
10.4.1.1. Brazil
10.4.1.1.1. Freezing of Gait Treatment Market: By Treatment, 2020-2030, USD (Million)
10.4.1.1.1. Freezing of Gait Treatment Market: By End User, 2020-2030, USD (Million)
10.4.1.2. Mexico
10.4.1.2.1. Freezing of Gait Treatment Market: By Treatment, 2020-2030, USD (Million)
10.4.1.2.1. Freezing of Gait Treatment Market: By End User, 2020-2030, USD (Million)
10.4.1.3. Rest of Latin America
10.4.1.3.1. Freezing of Gait Treatment Market: By Treatment, 2020-2030, USD (Million)
10.4.1.3.1. Freezing of Gait Treatment Market: By End User, 2020-2030, USD (Million)
11. Middle East and Africa Freezing of Gait Treatment Market, 2020-2030, USD (Million)
11.1. Market Overview
11.2. Freezing of Gait Treatment Market: By Treatment, 2020-2030, USD (Million)
11.3. Freezing of Gait Treatment Market: By End User, 2020-2030, USD (Million)
11.4.Freezing of Gait Treatment Market: By Region, 2020-2030, USD (Million)
11.4.1.Middle East and Africa
11.4.1.1. GCC
11.4.1.1.1. Freezing of Gait Treatment Market: By Treatment, 2020-2030, USD (Million)
11.4.1.1.1. Freezing of Gait Treatment Market: By End User, 2020-2030, USD (Million)
11.4.1.2. Africa
11.4.1.2.1. Freezing of Gait Treatment Market: By Treatment, 2020-2030, USD (Million)
11.4.1.2.1. Freezing of Gait Treatment Market: By End User, 2020-2030, USD (Million)
11.4.1.3. Rest of Middle East and Africa
11.4.1.3.1. Freezing of Gait Treatment Market: By Treatment, 2020-2030, USD (Million)
11.4.1.3.1. Freezing of Gait Treatment Market: By End User, 2020-2030, USD (Million)
12. Company Profile
12.1. Acorda Therapeutics
12.1.1. Company Overview
12.1.2. Financial Performance
12.1.3. Product Portfolio
12.1.4. Strategic Initiatives
12.2. The Michael J. Fox Foundation
12.2.1. Company Overview
12.2.2. Financial Performance
12.2.3. Product Portfolio
12.2.4. Strategic Initiatives
12.3. GYENNO
12.3.1. Company Overview
12.3.2. Financial Performance
12.3.3. Product Portfolio
12.3.4. Strategic Initiatives
12.4. National University of Ireland, Galway (NUI Galway)
12.4.1. Company Overview
12.4.2. Financial Performance
12.4.3. Product Portfolio
12.4.4. Strategic Initiatives
12.5. Kyungpook National University, Republic of Korea
12.5.1. Company Overview
12.5.2. Financial Performance
12.5.3. Product Portfolio
12.5.4. Strategic Initiatives
12.6. MedEXO Robotics
12.6.1. Company Overview
12.6.2. Financial Performance
12.6.3. Product Portfolio
12.6.4. Strategic Initiatives
List of Figures
Figure 1 Global Freezing of Gait Treatment Market: Market Coverage
Figure 2 Research Methodology and Data Sources
Figure 3 Market Size Estimation - Top Down & Bottom-Up Approach
Figure 4 Global Freezing of Gait Treatment Market: Quality Assurance
Figure 5 Global Freezing of Gait Treatment Market, By Treatment, 2021
Figure 6 Global Freezing of Gait Treatment Market, By End User, 2021
Figure 7 Global Freezing of Gait Treatment Market, By Geography, 2021
Figure 8 Market Geographical Opportunity Matrix - Global Freezing of Gait Treatment Market, 2021
Figure 9 Market Positioning of Key Freezing of Gait Treatment Market Players, 2021
Figure 10 Global Freezing of Gait Treatment Market - Tier Analysis - Percentage of Revenues by Tier Level, 2021 Versus 2030
Figure 11 Global Freezing of Gait Treatment Market, By Treatment, 2021 Vs 2030, %
Figure 12 Global Freezing of Gait Treatment Market, By End User, 2021 Vs 2030, %
Figure 13 U.S. Freezing of Gait Treatment Market (US$ Million), 2020 - 2030
Figure 14 Canada Freezing of Gait Treatment Market (US$ Million), 2020 - 2030
Figure 15 Rest of North America Freezing of Gait Treatment Market (US$ Million), 2020 - 2030
Figure 16 UK Freezing of Gait Treatment Market (US$ Million), 2020 - 2030
Figure 17 Germany Freezing of Gait Treatment Market (US$ Million), 2020 - 2030
Figure 18 Spain Freezing of Gait Treatment Market (US$ Million), 2020 - 2030
Figure 19 Italy Freezing of Gait Treatment Market (US$ Million), 2020 - 2030
Figure 20 France Freezing of Gait Treatment Market (US$ Million), 2020 - 2030
Figure 21 Rest of Europe Freezing of Gait Treatment Market (US$ Million), 2020 - 2030
Figure 22 China Freezing of Gait Treatment Market (US$ Million), 2020 - 2030
Figure 23 Japan Freezing of Gait Treatment Market (US$ Million), 2020 - 2030
Figure 24 India Freezing of Gait Treatment Market (US$ Million), 2020 - 2030
Figure 25 Australia Freezing of Gait Treatment Market (US$ Million), 2020 - 2030
Figure 26 South Korea Freezing of Gait Treatment Market (US$ Million), 2020 - 2030
Figure 27 Rest of Asia Freezing of Gait Treatment Market (US$ Million), 2020 - 2030
Figure 28 Brazil Freezing of Gait Treatment Market (US$ Million), 2020 - 2030
Figure 29 Mexico Freezing of Gait Treatment Market (US$ Million), 2020 - 2030
Figure 30 Rest of Latin America Freezing of Gait Treatment Market (US$ Million), 2020 - 2030
Figure 31 GCC Freezing of Gait Treatment Market (US$ Million), 2020 - 2030
Figure 32 Africa Freezing of Gait Treatment Market (US$ Million), 2020 - 2030
Figure 33 Rest of Middle East and Africa Freezing of Gait Treatment Market (US$ Million), 2020 - 2030
List of Tables
Table 1 Global Freezing of Gait Treatment Market By Treatment, 2020-2030, USD (Million)
Table 2 Global Freezing of Gait Treatment Market By End User, 2020-2030, USD (Million)
Table 3 North America Freezing of Gait Treatment Market By Treatment, 2020-2030, USD (Million)
Table 4 North America Freezing of Gait Treatment Market By End User, 2020-2030, USD (Million)
Table 5 U.S. Freezing of Gait Treatment Market By Treatment, 2020-2030, USD (Million)
Table 6 U.S. Freezing of Gait Treatment Market By End User, 2020-2030, USD (Million)
Table 7 Canada Freezing of Gait Treatment Market By Treatment, 2020-2030, USD (Million)
Table 8 Canada Freezing of Gait Treatment Market By End User, 2020-2030, USD (Million)
Table 9 Rest of North America Freezing of Gait Treatment Market By Treatment, 2020-2030, USD (Million)
Table 10 Rest of North America Freezing of Gait Treatment Market By End User, 2020-2030, USD (Million)
Table 11 UK and European Union Freezing of Gait Treatment Market By Treatment, 2020-2030, USD (Million)
Table 12 UK and European Union Freezing of Gait Treatment Market By End User, 2020-2030, USD (Million)
Table 13 UK Freezing of Gait Treatment Market By Treatment, 2020-2030, USD (Million)
Table 14 UK Freezing of Gait Treatment Market By End User, 2020-2030, USD (Million)
Table 15 Germany Freezing of Gait Treatment Market By Treatment, 2020-2030, USD (Million)
Table 16 Germany Freezing of Gait Treatment Market By End User, 2020-2030, USD (Million)
Table 17 Spain Freezing of Gait Treatment Market By Treatment, 2020-2030, USD (Million)
Table 18 Spain Freezing of Gait Treatment Market By End User, 2020-2030, USD (Million)
Table 19 Italy Freezing of Gait Treatment Market By Treatment, 2020-2030, USD (Million)
Table 20 Italy Freezing of Gait Treatment Market By End User, 2020-2030, USD (Million)
Table 21 France Freezing of Gait Treatment Market By Treatment, 2020-2030, USD (Million)
Table 22 France Freezing of Gait Treatment Market By End User, 2020-2030, USD (Million)
Table 23 Rest of Europe Freezing of Gait Treatment Market By Treatment, 2020-2030, USD (Million)
Table 24 Rest of Europe Freezing of Gait Treatment Market By End User, 2020-2030, USD (Million)
Table 25 Asia Freezing of Gait Treatment Market By Treatment, 2020-2030, USD (Million)
Table 26 Asia Freezing of Gait Treatment Market By End User, 2020-2030, USD (Million)
Table 27 China Freezing of Gait Treatment Market By Treatment, 2020-2030, USD (Million)
Table 28 China Freezing of Gait Treatment Market By End User, 2020-2030, USD (Million)
Table 29 Japan Freezing of Gait Treatment Market By Treatment, 2020-2030, USD (Million)
Table 30 Japan Freezing of Gait Treatment Market By End User, 2020-2030, USD (Million)
Table 31 India Freezing of Gait Treatment Market By Treatment, 2020-2030, USD (Million)
Table 32 India Freezing of Gait Treatment Market By End User, 2020-2030, USD (Million)
Table 33 Australia Freezing of Gait Treatment Market By Treatment, 2020-2030, USD (Million)
Table 34 Australia Freezing of Gait Treatment Market By End User, 2020-2030, USD (Million)
Table 35 South Korea Freezing of Gait Treatment Market By Treatment, 2020-2030, USD (Million)
Table 36 South Korea Freezing of Gait Treatment Market By End User, 2020-2030, USD (Million)
Table 37 Latin America Freezing of Gait Treatment Market By Treatment, 2020-2030, USD (Million)
Table 38 Latin America Freezing of Gait Treatment Market By End User, 2020-2030, USD (Million)
Table 39 Brazil Freezing of Gait Treatment Market By Treatment, 2020-2030, USD (Million)
Table 40 Brazil Freezing of Gait Treatment Market By End User, 2020-2030, USD (Million)
Table 41 Mexico Freezing of Gait Treatment Market By Treatment, 2020-2030, USD (Million)
Table 42 Mexico Freezing of Gait Treatment Market By End User, 2020-2030, USD (Million)
Table 43 Rest of Latin America Freezing of Gait Treatment Market By Treatment, 2020-2030, USD (Million)
Table 44 Rest of Latin America Freezing of Gait Treatment Market By End User, 2020-2030, USD (Million)
Table 45 Middle East and Africa Freezing of Gait Treatment Market By Treatment, 2020-2030, USD (Million)
Table 46 Middle East and Africa Freezing of Gait Treatment Market By End User, 2020-2030, USD (Million)
Table 47 GCC Freezing of Gait Treatment Market By Treatment, 2020-2030, USD (Million)
Table 48 GCC Freezing of Gait Treatment Market By End User, 2020-2030, USD (Million)
Table 49 Africa Freezing of Gait Treatment Market By Treatment, 2020-2030, USD (Million)
Table 50 Africa Freezing of Gait Treatment Market By End User, 2020-2030, USD (Million)
Table 51 Rest of Middle East and Africa Freezing of Gait Treatment Market By Treatment, 2020-2030, USD (Million)
Table 52 Rest of Middle East and Africa Freezing of Gait Treatment Market By End User, 2020-2030, USD (Million)
Companies Mentioned
- Acorda Therapeutics
- The Michael J. Fox Foundation
- GYENNO
- National University of Ireland
- Galway (NUI Galway)
- Kyungpook National University
- Republic of Korea
- MedEXO Robotics
- TABLE Teva Pharmaceuticals .
